News
The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...
20h
Zacks Investment Research on MSNIs Jazz Pharmaceuticals a Top Cannabis Investment for 2025?While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug ...
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
IPAX-Linz is a single-arm Phase 2 investigator-initiated trial (IIT). IPAX-Linz evaluates the safety, tolerability and preliminary efficacy of TLX101 therapy, in combination with external beam ...
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
The International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how ...
Presidential approval ratings provide a glimpse of how ... shows Trump's overall favorability at 48.1% versus 49.4% that disapprove, as of today. Note: Polls are constantly changing and different ...
The FDA is reviewing the BLA ... Arcutis Biotherapeutics is seeking to expand the approval of roflumilast foam to include the treatment of adults and adolescents 12 years and older with scalp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results